Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carson

Showing results (301-310 of 364) with videos related to

Pageof 37
Sort By:
Prostate Cancer and Prostatic Diseases|September 14, 2022
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Elife|September 26, 2015
Genomic DNA transposition induced by human PGBD5Anton G Henssen, Elizabeth Henaff, Eileen Jiang, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2023
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Journal of the National Cancer Institute|July 7, 2016
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States VeteransDaphne Y Xiao, Suhong Luo, Katiuscia O'Brian, et al.
Blood Advances|April 13, 2018
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with <i>FLT3</i>-ITD mutationsMark J Levis, Alexander E Perl, Jessica K Altman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, micro and delta opioid agonists: a micro addressJohn R Carson, Steven J Coats, Ellen E Codd, et al.
The Oncologist|September 20, 2013
Influence of body mass index on survival in veterans with multiple myelomaTracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
Pageof 37

Showing results (301-310 of 364) with videos related to

Sort By:
Pageof 37
Prostate Cancer and Prostatic Diseases|September 14, 2022
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Elife|September 26, 2015
Genomic DNA transposition induced by human PGBD5Anton G Henssen, Elizabeth Henaff, Eileen Jiang, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2023
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Journal of the National Cancer Institute|July 7, 2016
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States VeteransDaphne Y Xiao, Suhong Luo, Katiuscia O'Brian, et al.
Blood Advances|April 13, 2018
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with <i>FLT3</i>-ITD mutationsMark J Levis, Alexander E Perl, Jessica K Altman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, micro and delta opioid agonists: a micro addressJohn R Carson, Steven J Coats, Ellen E Codd, et al.
The Oncologist|September 20, 2013
Influence of body mass index on survival in veterans with multiple myelomaTracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
Pageof 37